88 related articles for article (PubMed ID: 19712374)
41. A comprehensive evaluation of colonic mucosal isolates of Sutterella wadsworthensis from inflammatory bowel disease.
Mukhopadhya I; Hansen R; Nicholl CE; Alhaidan YA; Thomson JM; Berry SH; Pattinson C; Stead DA; Russell RK; El-Omar EM; Hold GL
PLoS One; 2011; 6(10):e27076. PubMed ID: 22073125
[TBL] [Abstract][Full Text] [Related]
42. Intestinal microbiota in human health and disease: the impact of probiotics.
Gerritsen J; Smidt H; Rijkers GT; de Vos WM
Genes Nutr; 2011 Aug; 6(3):209-40. PubMed ID: 21617937
[TBL] [Abstract][Full Text] [Related]
43. Mucin-bacterial interactions in the human oral cavity and digestive tract.
Derrien M; van Passel MW; van de Bovenkamp JH; Schipper RG; de Vos WM; Dekker J
Gut Microbes; 2010 Jul; 1(4):254-268. PubMed ID: 21327032
[TBL] [Abstract][Full Text] [Related]
44. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.
Walker AW; Sanderson JD; Churcher C; Parkes GC; Hudspith BN; Rayment N; Brostoff J; Parkhill J; Dougan G; Petrovska L
BMC Microbiol; 2011 Jan; 11():7. PubMed ID: 21219646
[TBL] [Abstract][Full Text] [Related]
45. Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions.
Bibiloni R; Schiffrin EJ
Int J Inflam; 2010 Sep; 2010():386956. PubMed ID: 21152123
[TBL] [Abstract][Full Text] [Related]
46. In vitro communities derived from oral and gut microbial floras inhibit the growth of bacteria of foreign origins.
He X; Tian Y; Guo L; Ano T; Lux R; Zusman DR; Shi W
Microb Ecol; 2010 Oct; 60(3):665-76. PubMed ID: 20625712
[TBL] [Abstract][Full Text] [Related]
47. Phylogenetic analysis of 16S rRNA gene sequences reveals distal gut bacterial diversity in wild wolves (Canis lupus).
Zhang H; Chen L
Mol Biol Rep; 2010 Dec; 37(8):4013-22. PubMed ID: 20306230
[TBL] [Abstract][Full Text] [Related]
48. Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains.
Martinez-Medina M; Mora A; Blanco M; López C; Alonso MP; Bonacorsi S; Nicolas-Chanoine MH; Darfeuille-Michaud A; Garcia-Gil J; Blanco J
J Clin Microbiol; 2009 Dec; 47(12):3968-79. PubMed ID: 19828750
[TBL] [Abstract][Full Text] [Related]
49. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.
Codling C; O'Mahony L; Shanahan F; Quigley EM; Marchesi JR
Dig Dis Sci; 2010 Feb; 55(2):392-7. PubMed ID: 19693670
[TBL] [Abstract][Full Text] [Related]
50. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases.
Peterson DA; Frank DN; Pace NR; Gordon JI
Cell Host Microbe; 2008 Jun; 3(6):417-27. PubMed ID: 18541218
[TBL] [Abstract][Full Text] [Related]
51. Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.
De Hertogh G; Aerssens J; Geboes KP; Geboes K
World J Gastroenterol; 2008 Feb; 14(6):845-52. PubMed ID: 18240341
[TBL] [Abstract][Full Text] [Related]
52. The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract.
Derrien M; Collado MC; Ben-Amor K; Salminen S; de Vos WM
Appl Environ Microbiol; 2008 Mar; 74(5):1646-8. PubMed ID: 18083887
[TBL] [Abstract][Full Text] [Related]
53. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.
Frank DN; St Amand AL; Feldman RA; Boedeker EC; Harpaz N; Pace NR
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13780-5. PubMed ID: 17699621
[TBL] [Abstract][Full Text] [Related]
54. Antioxidant effects of metronidazole in colonic tissue.
Pélissier MA; Marteau P; Pochart P
Dig Dis Sci; 2007 Jan; 52(1):40-4. PubMed ID: 17151808
[TBL] [Abstract][Full Text] [Related]
55. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.
Scanlan PD; Shanahan F; O'Mahony C; Marchesi JR
J Clin Microbiol; 2006 Nov; 44(11):3980-8. PubMed ID: 16988018
[TBL] [Abstract][Full Text] [Related]
56. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach.
Manichanh C; Rigottier-Gois L; Bonnaud E; Gloux K; Pelletier E; Frangeul L; Nalin R; Jarrin C; Chardon P; Marteau P; Roca J; Dore J
Gut; 2006 Feb; 55(2):205-11. PubMed ID: 16188921
[TBL] [Abstract][Full Text] [Related]
57. Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA.
Seksik P; Lepage P; de la Cochetière MF; Bourreille A; Sutren M; Galmiche JP; Doré J; Marteau P
J Clin Microbiol; 2005 Sep; 43(9):4654-8. PubMed ID: 16145122
[TBL] [Abstract][Full Text] [Related]
58. Colonic microbiota signatures across five northern European countries.
Lay C; Rigottier-Gois L; Holmstrøm K; Rajilic M; Vaughan EE; de Vos WM; Collins MD; Thiel R; Namsolleck P; Blaut M; Doré J
Appl Environ Microbiol; 2005 Jul; 71(7):4153-5. PubMed ID: 16000838
[TBL] [Abstract][Full Text] [Related]
59. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon.
Walker AW; Duncan SH; McWilliam Leitch EC; Child MW; Flint HJ
Appl Environ Microbiol; 2005 Jul; 71(7):3692-700. PubMed ID: 16000778
[TBL] [Abstract][Full Text] [Related]
60. Molecular inventory of faecal microflora in patients with Crohn's disease.
Mangin I; Bonnet R; Seksik P; Rigottier-Gois L; Sutren M; Bouhnik Y; Neut C; Collins MD; Colombel JF; Marteau P; Doré J
FEMS Microbiol Ecol; 2004 Oct; 50(1):25-36. PubMed ID: 19712374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
